Access cutting-edge age-related macular degeneration treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access age-related macular degeneration specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related age-related macular degeneration treatment provided free
This study will evaluate the success and safety of subretinal surgical delivery as well as the preliminary activity of OpRegen in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). All endpoints are assessed for the study eye unless otherwise indicated. The substudy will evaluate the operational feasibility and scientific interpretability of incorporating AO retinal imaging using the EarlySight Cellularis® Discovery device. Participants who have fulfi
Sponsor: Genentech, Inc.
Check if you qualify for this age-related macular degeneration clinical trial in Baltimore, MD
If you're searching for age-related macular degeneration treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.